Back to Journals » Biologics: Targets and Therapy » Volume 13

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Total article views   HTML views PDF downloads Totals
7,016 Dovepress* 6,332+ 1,568 7,900
PubMed Central* 684 290 974
Totals 7,016 1,858 8,874
*Since 3 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar